SPEC PerkinElmer 10.13
News|Articles|February 3, 2025

Blood-Glucose Testing: AI and FT-IR Claim Improved Accuracy to 98.8%

A research team is claiming significantly enhanced accuracy of non-invasive blood-glucose testing by upgrading Fourier transform infrared spectroscopy (FT-IR) with multiple-reflections, quantum cascade lasers, two-dimensional correlation spectroscopy, and machine learning. The study, published in Spectrochimica Acta Part A, reports achieving a record-breaking 98.8% accuracy, surpassing previous benchmarks for non-invasive glucose detection.

A study led by Liying Song, Zhiqiang Han, Po-Wan Shum, and Woon-Ming Lau has successfully transformed the accuracy of non-invasive blood-glucose testing. Conducted at Linyi University and the University of Science and Technology Beijing, the research integrates multiple technological advancements to overcome limitations in traditional Fourier transform-infrared (FT-IR)-based glucose testing (2).

Blood-Glucose Testing

Current non-invasive glucose testing methods rely on attenuated total reflection (ATR) combined with infrared spectroscopy, specifically ATR FT-IR, where infrared light is reflected from sample tissue using the ATR phenomenon to detect low signal glucose levels in a complex background. However, this approach struggles with sensitivity and interference from other biomolecules and from optical differences in tissues. To address these challenges, the research team implemented three key innovations: a multi-pass ATR reflections setup, quantum cascade laser (QCL) illumination, and advanced machine learning (ML) data analysis techniques (2).

Upgrading FT-IR for Superior Sensitivity

The first enhancement involved replacing the conventional single-pass ATR setup with a multiple-reflection ATR (MATR) configuration. This modification increased the signal-to-noise ratio by a factor of two to three, allowing for clearer glucose detection in complex biological tissue samples (2).

The second major enhancement replaced the traditional infrared lamp with a QCL, further tripling the signal-to-noise performance. The QCL, operating between 935 and 1128 cm⁻¹, precisely targeted glucose’s mid-infrared spectral signature, improving accuracy and reliability.

Leveraging Two-Dimensional Correlation Spectroscopy and AI

Beyond hardware improvements, the study leveraged two-dimensional correlation spectroscopy (2D-COS) to refine spectral analysis. Unlike traditional one-dimensional spectral methods, 2D-COS analyzes spectral variations across two wavelength axes, effectively minimizing interference from overlapping biomolecular signals (2).

To maximize analytical precision, the researchers also incorporated ML-based decision trees for hyperglycemia screening. They tested multiple algorithms, with a final approach combining three decision-tree models and a majority-voting mechanism. This strategy significantly improved classification performance, achieving an unprecedented 98.8% accuracy in distinguishing diabetic from non-diabetic glucose levels (2).

Extensive Testing and Validation

The study’s rigorous validation process involved 24 glucose concentrations (70–300 mg/dL) spanning both non-diabetic and diabetic ranges. Each concentration underwent 100 repeated spectral measurements, totaling 7,200 test spectra. The MATR-QCL-2D-COS combination yielded the best results, demonstrating not only high accuracy but also consistency across samples (2).

Implications for Diabetes Management

This research marks a notable step toward practical, non-invasive glucose monitoring solutions. By surpassing the accuracy benchmarks set by previous studies, including those requiring mechanical pressure for sampling, the upgraded FT-IR method could soon become a viable alternative to traditional blood-based glucose tests (2).

The integration of ML with advanced spectroscopic techniques opens new possibilities for rapid, painless, and highly accurate diabetes screening. As non-invasive technologies continue to advance, this breakthrough may pave the way for real-world applications in continuous glucose monitoring and early diabetes detection.

References

(1) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Diabetes Home Page. https://www.niddk.nih.gov/health-information/diabetes (accessed 2025-01-28)

(2) Song, L.; Han, Z.; Shum, P. W.; and Lau, W. M. Enhancing the Accuracy of Blood-Glucose Tests by Upgrading FTIR with Multiple-Reflections, Quantum Cascade Laser, Two-Dimensional Correlation Spectroscopy, and Machine Learning. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2025, 327, 125400. DOI: 10.1016/j.saa.2024.125400


Related to this article

Human body wireframe on glowing platform undergoing futuristic body scan. © sergray(noAIelemens) -chronicles-stock.adobe.com
Jurgen Popp, Thomas Mayerhofer, and colleagues at Leibniz IPHT and Friedrich Schiller University Jena introduce the Personalized Optical Digital Twin (PODT), a Photonics21 contribution to Europe's Virtual Human Twin ecosystem that connects molecular photonics—Raman blood analysis, coherent Raman tissue imaging, and multimodal endomicroscopy—with longitudinal physiology and clinical data. Drawing on the published multicenter INTELLIGENCE trials, the authors argue that technical feasibility and clinical utility must be evaluated separately as the field moves toward Europe's FP10 research agenda.
The Mismatch Between Education and Industry
Panelists from the Society for Applied Spectroscopy, the Coblentz Society, Syensqo, Specac, and the University of Georgia discuss how a mismatch between academic curricula and industry practice leaves many analysts unsure when, and how, to use infrared and Raman spectroscopy.